You are currently viewing a new version of our website. To view the old version click .

Clinical Immunology: Diseases Control and Prevention

This special issue belongs to the section “Vaccines, Clinical Advancement, and Associated Immunology“.

Special Issue Information

Dear Colleagues,

Clinical immunology provides the recent and core information required to understand diseases with an immunological basis, which covers the underlying pathophysiology, the signs and symptoms of disease, the investigations required, and guidance for the management of patients. With the exploration of clinical studies in the control and prevention of general diseases through immunology research, the application of practical immunological techniques and methods and will further introduce new and emerging research.

Recent discoveries from basic and clinical research in the field of clinical immunology have led to significant progress, including a better understanding of the natural histories of diseases, risk predictors, and treatment options and strategies. This knowledge developed from a mechanistic approach focusing on disease symptoms and complex immunological pathways as well. However, the complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient populations, and accessing internal tissues for testing. Therefore, the scope and aim of this Special Issue is to cover recent studies on medicines and immunological therapies in clinical research, and to deliver a comprehensive concept and examples in daily life.

Dr. Shailendra Pratap Singh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic syndrome
  • clinical infections
  • immunology therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X